Source: Biospectrum Asia

Daiichi Sankyo: Daiichi Sankyo and Nosis Biosciences partner to advance RNA medicines

Daiichi, Nosis Biosciences partner to advance RNA medicines

Read full article »
Daiichi Sankyo's Competitors | Daiichi Sankyo's News | Daiichi Sankyo's Financials
Stay up-to-date with the latest news on Daiichi Sankyo
Annual Revenue
$10-50B
Employees
10-50K
Hiroyuki Okuzawa's photo - President & CEO of Daiichi Sankyo

President & CEO

Hiroyuki Okuzawa

CEO Approval Rating

- -/100

Read more
Stay up-to-date with the latest news on Daiichi Sankyo